Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe Review


Authors: Veronesi, G.; Baldwin, D. R.; Henschke, C. I.; Ghislandi, S.; Iavicoli, S.; Oudkerk, M.; De Koning, H. J.; Shemesh, J.; Field, J. K.; Zulueta, J. J.; Horgan, D.; Navarrete, L. F.; Infante, M. V.; Novellis, P.; Murray, R. L.; Peled, N.; Rampinelli, C.; Rocco, G.; Rzyman, W.; Scagliotti, G. V.; Tammemagi, M. C.; Bertolaccini, L.; Triphuridet, N.; Yip, R.; Rossi, A.; Senan, S.; Ferrante, G.; Brain, K.; van der Aalst, C.; Bonomo, L.; Consonni, D.; Van Meerbeeck, J. P.; Maisonneuve, P.; Novello, S.; Devaraj, A.; Saghir, Z.; Pelosi, G.
Review Title: Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe
Abstract: Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the disease. European mortality data has recently become available from the Nelson randomised controlled trial, which confirmed lung cancer mortality reductions by 26% in men and 39–61% in women. Recent studies in Europe and the USA also showed positive results in screening workers exposed to asbestos. All European experts attending the “Initiative for European Lung Screening (IELS)”—a large international group of physicians and other experts concerned with lung cancer—agreed that LDCT-LCS should be implemented in Europe. However, the economic impact of LDCT-LCS and guidelines for its effective and safe implementation still need to be formulated. To this purpose, the IELS was asked to prepare recommendations to implement LCS and examine outstanding issues. A subgroup carried out a comprehensive literature review on LDCT-LCS and presented findings at a meeting held in Milan in November 2018. The present recommendations reflect that consensus was reached. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords: mortality; cancer risk; radiation dose; demography; consensus; computer assisted tomography; cancer screening; lung cancer; smoking cessation; smoking; practice guideline; prediction; risk assessment; self report; netherlands; health care policy; cost effectiveness analysis; health care cost; health program; population research; screening; incidental finding; false positive result; quality adjusted life year; low dose; computed tomography; chronic obstructive lung disease; volumetry; reduction; asbestos; lung emphysema; implementation; statement; low dose computed tomography; human; article; coronary artery calcification
Journal Title: Cancers
Volume: 12
Issue: 6
ISSN: 2072-6694
Publisher: MDPI  
Date Published: 2020-06-01
Start Page: 1672
Language: English
DOI: 10.3390/cancers12061672
PROVIDER: scopus
PMCID: PMC7352874
PUBMED: 32599792
DOI/URL:
Notes: Article -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gaetano Rocco
    131 Rocco